The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKcs-mediated DNA damage responses

被引：0
|
作者：
Mukherjee, Bipasha [1 ]
Tomimatsu, Nozomi [1 ]
Amancherla, Kaushik [1 ]
Camacho, Cristel [1 ]
Burma, Sandeep [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3745
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3745
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Synergistic anti-leukemia activity of the dual mTOR/PI3K inhibitor NVP-BEZ235 with the BCL-2 inhibitor venetoclax
    Niedermayer, A.
    Enzenmueller, S.
    Seyfried, F.
    Debatin, K. M.
    Meyer, L. H.
    KLINISCHE PADIATRIE, 2023, 235 (03): : 199 - 199
  • [32] NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations
    Serra, Violeta
    Markman, Ben
    Scaltriti, Maurizio
    Eichhorn, Pieter J. A.
    Valero, Vanesa
    Guzman, Marta
    Luisa Botero, Maria
    Llonch, Elisabeth
    Atzori, Francesco
    Di Cosimo, Serena
    Maira, Michel
    Garcia-Echeverria, Carlos
    Lluis Parra, Josep
    Arribas, Joaquin
    Baselga, Jose
    CANCER RESEARCH, 2008, 68 (19) : 8022 - 8030
  • [33] NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells
    Moon, Du G.
    Lee, Sang E.
    Oh, Mi M.
    Lee, Sang C.
    Jeong, Seong J.
    Hong, Sung K.
    Yoon, Cheol Y.
    Byun, Seok S.
    Park, Hong S.
    Cheon, Jun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (03) : 1027 - 1035
  • [34] Effective Targeting of the PI3-K Pathway in CLL with NVP-BEZ235, a Novel Orally Available Dual PI3K/mTOR Inhibitor
    Shehata, Medhat
    Schnabl, Susanne
    Demirtas, Dita
    Tauber, Stefanie
    Hilgarth, Martin
    Bilban, Martin
    Vanura, Katrina
    Porpaczy, Edit
    Fonatsch, Christa
    Stilgenbauer, Stephan
    Schwarzmeier, Josef D.
    Hubmann, Rainer
    Gaiger, Alexander
    Zielinski, Christoph
    Maira, Sauveur-Michel
    Garcia-Echeverria, Carlos
    Hackl, Wolfgang
    Jaeger, Ulrich
    BLOOD, 2008, 112 (11) : 1086 - 1086
  • [35] The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer
    Awasthi, Niranjan
    Yen, Peter L.
    Schwarz, Margaret A.
    Schwarz, Roderich E.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (03) : 784 - 791
  • [36] Activity of dual PI3K/mTOR inhibitor, NVP-BEZ235, and mTOR inhibitor, RAD001 (everolimus), in endometrial cancer cell lines.
    Shoji, K.
    Oda, K.
    Nakagawa, S.
    Ikeda, Y.
    Kuramoto, H.
    Nishida, N.
    Kawana, K.
    Yano, T.
    Kozuma, S.
    Taketani, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] NVP-BEZ235, A DUAL PI3K/MTOR INHIBITOR SYNERGISTICALLY POTENTIATES ANTITUMOR EFFECT OF CISPLATIN IN BLADDER CANCER CELLS
    Park, Hong Seok
    Yoon, Cheol Yong
    Cheon, Jun
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A206 - A206
  • [38] NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro
    Wen-juan Wang
    Lin-mei Long
    Neng Yang
    Qing-qing Zhang
    Wen-jun Ji
    Jiang-hu Zhao
    Zheng-hong Qin
    Zhong Wang
    Gang Chen
    Zhong-qin Liang
    Acta Pharmacologica Sinica, 2013, 34 : 681 - 690
  • [39] NVP-BEZ235, a dual PI3K/mTOR inhibitor, suppress tumorigenicity of ovarian clear cell carcinoma cells.
    Oishi, Tetsuro
    Itamochi, Hiroaki
    Kudoh, Akiko
    Nonaka, Michiko
    Sato, Seiya
    Naniwa, Jun
    Sato, Shinya
    Shimada, Muneaki
    Terakawa, Naoki
    Kigawa, Junzo
    Harada, Tasuku
    CANCER RESEARCH, 2012, 72
  • [40] NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro
    Wang, Wen-juan
    Long, Lin-mei
    Yang, Neng
    Zhang, Qing-qing
    Ji, Wen-jun
    Zhao, Jiang-hu
    Qin, Zheng-hong
    Wang, Zhong
    Chen, Gang
    Liang, Zhong-qin
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (05) : 681 - 690
12345